This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
L+A is proud to welcome Dr. Vincent Wong to our Editorial Team as a Medical Contributor. He has authored a textbook on Aesthetic Medicine, published over 35 scientific papers, and serves as a Global Advisor for major pharmaceutical companies.
In theory, everyone can tap into these materials, but true innovation in skincare products is made through formulation and application. We all have access to the same ingredients, but it’s up to the chemist to find innovation in product formulation. I think of it like baking a cake. Skincare works in exactly the same way.
Novartis is the official first-in-category corporate pharmaceutical partner of the National Football League (NFL). “At the NFL, we’re always looking for new ways to provide the highest level of care to our players, including through collaboration with experts across the medical field.
In an industry racing toward innovation and obsessed with results, theres a rare breed of skincare brand that manages to balance clinical-grade technology with the power of plants. This innovation became known as Permeation Enhancement Technology (P.E.T.) , and in 2002, it powered an FDA-approved pharmaceutical product.
More than 200 residents, medical students and Fellow members have committed to volunteer for MBWS outreach events at universities, hospitals, and community venues, with a planned distribution of 10,000 gift bags with tips for managing winter skin and free moisturizing products generously provided by campaign sponsor, Clinique.
This article will explore the key developments in the use of dermal fillers, including the trend of dissolving fillers, an emphasis on skin quality, the rise of combination treatments, and my personal experiences with innovative treatment protocols in my clinic.
Phyllis Hsieh is the visionary behind Conrex Pharmaceutical Corp. Her commitment to innovation and quality has solidified SESHA’s reputation as a trusted leader in professional skincare worldwide. The Permeation Enhancement Technology is FDA-approved in pharmaceuticals.
Together with the Arthritis National Research Foundation (ANRF), PeDRA has opened applications for the Rheum for Kids: Pediatric Skin and Joint Grant , a funding opportunity designed to support early-career researchers in advancing innovative projects in pediatric dermatology and pediatric rheumatology.
Tildrakizumab-asmn (Ilumya, Sun Pharmaceutical Industries, Inc.) “As a company dedicated to developing innovative therapies which help improve quality of life for patients, these data, along with our existing data in scalp psoriasis, reinforces the benefits of ILUMYA in difficult to treat populations.” In addition, 29.4%
IBA supports creative, innovative companies from startups to established multinational businesses of all sizes succeed in the rapidly changing, highly competitive global cosmetics and personal care industry. in Regulatory Affairs for Drugs, Biologics & Medical Devices from Northeastern University. She holds a B.S.
Verrica Pharmaceuticals Files Lawsuit Against Canadian Drug Manufacturer for False Advertising, Unfair Competition Verrica Pharmaceuticals Inc. In addition, throughout 2024, Sanofi intends to implement coverage of miscellaneous non-medical expenses.
LEO Pharma recently acquired TMB-001 and other assets from Timber Pharmaceuticals following Timber’s Chapter 11 bankruptcy filing. This is an innovative topical isotretinoin that is being investigated for application on a large body surface. The reformulation has received orphan, fast track, and breakthrough designation by the FDA.
The increasing popularity of weight loss medications like semaglutide and tirzepatide highlights the effectiveness of GLP-1 receptor agonists in helping individuals manage their weight. In clinical trials, medications like semaglutide have shown substantial results. However, as with any medication, there are potential side effects.
Nicholas Norwitz, a Harvard medical student who holds a doctorate in metabolism and nutrition from the University of Oxford, has explored uncharted territory in cholesterol management through an innovative experiment. Oreos vs. Statins in LMHR Cholesterol Management Imagine lowering your cholesterol with Oreos instead of medication.
About the brand: A multifaceted brand with a philosophy of protecting and pampering the skin, ATZEN fuses the best of cosmetic technology and natural skincare, by combining pharmaceutical grade, green, and cosmeceutical ingredients. Why you’ll love it: Beautiful results with no downtime. Thank you M.A.D. for that bit of help!
Alys Pharmaceuticals, Inc. Alys combines six asset-centric Medicxi companies including Al Aldena Therapeutics, Graegis Pharmaceuticals, Granular Therapeutics, Klirna Biotech, Nira Biosciences and Vimela Therapeutics. ” The post Get to Know Alys Pharmaceuticals, Inc. ” The post Get to Know Alys Pharmaceuticals, Inc.
Innovations like circulating tumor DNA (ctDNA) detection are paving the way for active surveillance to become a more prevalent option in managing solid tumors, explained Dr. Nathan Goodyear, an integrative health physician specializing in oncology, in an interview with The Epoch Times. Williams remarked.
However, medications that are already authorized are just a small percentage of what's been studied. Many researchers are still trying to find and develop other medications that can treat or prevent COVID-19. The product is authorized as a medical device targeting COVID-19 in India, Israel, Bahrain, Indonesia and Thailand.
This is the] reason why the development of new strategies, including the chemical modification of carnosine or its vehiculation into innovative drug delivery systems (DDS), aiming at increasing its bioavailability and/or at facilitating the site-specific transport to different tissues, is of utmost importance.”
A cosmeceutical is essentially a skincare product that contains a biologically active compound that is thought to have pharmaceutical effects on the skin. Both pharmaceutical and cosmeceutical grade skin care products actively effect skin at a cellular level, whereas cosmetic products have a shorter-term effect.
Because our medical system is not geared towards prevention … We’re very much waiting for a house to be engulfed in flames before we decide to spit a little bit of water on it, right? That’s what we don’t have very good success with in Western medical treatment strategies.” It is just that.
In 2023, dermatologists and their patients welcomed new drugs for acne, psoriasis, alopecia areata, and more, and 2024 promises to deliver real-world data on these medications along with even more therapeutic innovations across the spectrum of cutaneous diseases. We will, for sure, have new medications for chronic urticaria.”
Some researchers are looking for innovative ways to fight cancer. According to a 2021 study published in Advanced Pharmaceutical Bulletin (APB), epidemiological evidence shows a clear link between fungal infections and cancer development. Although antifungal medications are available, they can have side effects.
Now, were taking it a step further with the launch of The Medical Aesthetic Report a dedicated category of articles written exclusively by our Medical Contributors. What is The Medical Aesthetic Report? Be sure to subscribe to L+A so you never miss an update from The Medical Aesthetic Report.
Rosenberg, MD, is Verrica Pharmaceuticals Inc.s new Chief Medical Officer (CMO). Dr. Rosenberg led the clinical development and approval of Xepi, a topical antibiotic for the treatment of impetigo, at Medimetriks Pharmaceuticals. 2024 Inducement Plan (the Inducement Plan), effective as of March 24, 2025.
March 2025 L+A Report 5 Must Have Modalities In Modern Medical Aesthetics Aesthetic device technology in the medical + spa skincare industry is evolving rapidly, with cutting-edge technologies transforming how professionals approach skin and body treatments.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content